PubMed

Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.

Levin K, Hother-Nielsen O, Henriksen JE, Beck-Nielsen H.

Diabetes Care. 2004 Jan;27(1):148-54.PMID: 14693981 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.

Ann Intern Med. 1998 Feb 1;128(3):176-85.PMID: 9454525 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.

Diabetes. 2000 Apr;49(4):633-9.PMID: 10871202 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J.

N Engl J Med. 1994 Nov 3;331(18):1188-93.PMID: 7935656 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.

Meyer MM, Levin K, Grimmsmann T, Perwitz N, Eirich A, Beck-Nielsen H, Klein HH.

Diabetes. 2002 Sep;51(9):2691-7.PMID: 12196460 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

Frias JP, Yu JG, Kruszynska YT, Olefsky JM.

Diabetes Care. 2000 Jan;23(1):64-9.PMID: 10857970 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

Kumar S, Boulton AJ, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P.

Diabetologia. 1996 Jun;39(6):701-9. Erratum in: Diabetologia 1996 Oct;39(10):1245. PMID: 8781766 [PubMed - indexed for MEDLINE]Related articles

Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.

Kumar S, Prange A, Schulze J, Lettis S, Barnett AH.

Diabet Med. 1998 Sep;15(9):772-9.PMID: 9737807 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.

Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA.

Diabetes. 1996 Nov;45(11):1572-9.PMID: 8866563 [PubMed - indexed for MEDLINE]Related articles

Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.

Sironi AM, Vichi S, Gastaldelli A, Pecori N, Anichini R, Foot E, Seghieri G, Ferrannini E.

Clin Pharmacol Ther. 1997 Aug;62(2):194-202.PMID: 9284856 [PubMed - indexed for MEDLINE]Related articles

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.

Diabetes. 1999 Dec;48(12):2414-21.PMID: 10580431 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

Willi SM, Kennedy A, Wallace P, Ganaway E, Rogers NL, Garvey WT.

Diabetes. 2002 Oct;51(10):2895-902.PMID: 12351424 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.

Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM.

Diabetes. 1997 Nov;46(11):1678-83.PMID: 9356012 [PubMed - indexed for MEDLINE]Related articles

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

Antonucci T, Whitcomb R, McLain R, Lockwood D, Norris RM.

Diabetes Care. 1997 Feb;20(2):188-93. Erratum in: Diabetes Care 1998 Apr;21(4):678. PMID: 9118772 [PubMed - indexed for MEDLINE]Related articles

Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.

Miles PD, Higo K, Romeo OM, Lee MK, Rafaat K, Olefsky JM.

Diabetes. 1998 Mar;47(3):395-400.PMID: 9519745 [PubMed - indexed for MEDLINE]Related articlesFree article

Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

Willi SM, Kennedy A, Brant BP, Wallace P, Rogers NL, Garvey WT.

Diabetes Res Clin Pract. 2002 Nov;58(2):87-96.PMID: 12213349 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

Cusi K, Consoli A, DeFronzo RA.

J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives.

Hulstrøm V, Højlund K, Vinten J, Beck-Nielsen H, Levin K.

Diabetes Obes Metab. 2008 Nov;10(11):1019-28. Epub 2008 Feb 18.PMID: 18284435 [PubMed - indexed for MEDLINE]Related articles